Evidence map›Paper›PMID 19616560›Full record

ArticleJournal of molecular biology2009

Highly cooperative recruitment of Ets-1 and release of autoinhibition by Pax5.

Daniel Fitzsimmons, Kara Lukin, Ryan Lutz, Colin W Garvie, Cynthia Wolberger, James Hagman

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. ETS1 Function in Leukemia and Lymphoma.Advances in experimental medicine and biology · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review of Ets1 structure, function, and roles in immunity.Cellular and molecular life sciences : CMLS · 2013
    Review
  14. Article
  15. Article
  16. Review
  17. Molecular mechanisms of ETS transcription factor-mediated tumorigenesis.Critical reviews in biochemistry and molecular biology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Daniel FitzsimmonsIntegrated Department of Immunology, National Jewish Medical and Research Center, Denver, CO 80206, USA.
Kara Lukin
Ryan Lutz
Colin W Garvie
Cynthia Wolberger
James Hagman
University of Colorado Denver · USJohns Hopkins University · USUniversity of Maryland, Baltimore County · US

Funding

THE REGULATION OF V ALPHA 7 EXPRESSING T CELLSP01AI022295 · NIAID · NATIONAL JEWISH HEALTH · PI REFAELI, YOSEF · 1985 to 2011
$11.7M
Function and Regulation of Early B Cell Factor (EBF)R01AI054661 · NIAID · NATIONAL JEWISH HEALTH · PI HAGMAN, JAMES R. · 2004 to 2011
$2.9M
Transcriptional Control and Lineage Commitment by Pax-5R01AI056322 · NIAID · NATIONAL JEWISH HEALTH · PI HAGMAN, JAMES R · 2003 to 2007
$1.5M
REGULATION OF B CELL DIFFERENTIATION IN VITROR01AI037574 · NIAID · NATIONAL JEWISH HEALTH · PI HAGMAN, JAMES R · 1997 to 2001
$547k
NIAID NIH HHS AI054661NIAID NIH HHS AI056322NIAID NIH HHS P01 AI022295NIAID NIH HHS P01 AI22295NIAID NIH HHS R01 AI037574NIAID NIH HHS R01 AI054661NIAID NIH HHS R01 AI056322NIAID NIH HHS R01 AI37574
6 · The paper itself

Abstract

Pax5 (paired box binding factor 5) is a critical regulator of transcription and lineage commitment in B lymphocytes. In B cells, mb-1 (Ig-alpha/immunoglobulin-associated alpha) promoter transcription is activated by Pax5 through its recruitment of E74-like transforming sequence (Ets) family proteins to a composite site, the P5-EBS (Pax5-Ets binding site). Previously, X-ray crystallographic analysis revealed a network of contacts between the DNA-binding domains of Pax5 and Ets-1 while bound to the P5-EBS. Here, we report that Pax5 assembles these ternary complexes via highly cooperative interactions that overcome the autoinhibition of Ets-1. Using recombinant proteins, we calculated K(d(app)) values for the binding of Pax5, Ets-1, and GA-binding proteins, separately or together, to the P5-EBS. By itself, Pax5 binds the P5-EBS with high affinity (K(d) approximately equal 2 nM). Ets-1(331-440) bound the P5-EBS by itself with low affinity (K(d)=136 nM). However, autoinhibited Ets-1(280-440) alone does not bind detectably to the suboptimal sequences of the P5-EBS. Recruitment of Ets-1(331-440) or Ets-1(280-440) resulted in highly efficient ternary complex assembly with Pax5. Pax5 counteracts autoinhibition and increases binding of Ets-1 of the mb-1 promoter by >1000-fold. Mutation of Pax5 Gln22 to alanine (Q22A) enhances promoter binding by Pax5; however, Q22A greatly reduces recruitment of Ets-1(331-440) and Ets-1(280-440) by Pax5 (8.9- or >300-fold, respectively). Thus, Gln22 of Pax5 is essential for overcoming Ets-1 autoinhibition. Pax5 wild type and Q22A each recruited GA-binding protein alpha/beta1 to the mb-1 promoter with similar affinities, but recruitment was less efficient than that of Ets-1 (reduced by approximately 8-fold). Our results suggest a mechanism that allows Pax5 to overcome autoinhibition of Ets-1 DNA binding. In summary, these data illustrate requirements for partnerships between Ets proteins and Pax5.

Indexed as

Amino Acid SubstitutionDNAElectrophoretic Mobility Shift AssayHumansKineticsMutagenesis, Site-DirectedMutant ProteinsPAX5 Transcription FactorPromoter Regions, GeneticProtein BindingProto-Oncogene Protein c-ets-1DNAMutant ProteinsPAX5 protein, humanPAX5 Transcription FactorProto-Oncogene Protein c-ets-1

Identifiers

PMID19616560
PMCPMC2763353
OpenAlexW2039746209

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.